BALF cytokines in different phenotypes of chronic lung allograft dysfunction in lung transplant patients

被引:28
|
作者
Berastegui, Cristina [1 ]
Gomez-Olles, Susana [1 ,2 ]
Sanchez-Vidaurre, Sara [1 ]
Culebras, Mario [1 ]
Monforte, Victor [1 ,2 ]
Lopez-Meseguer, Manuel [1 ]
Bravo, Carlos [1 ,2 ]
Ramon, Maria-Antonia [1 ]
Romero, Laura [3 ]
Sole, Joan [3 ]
Cruz, Maria-Jesus [1 ,2 ]
Roman, Antonio [1 ,2 ]
机构
[1] Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Serv Pneumol, Barcelona, Spain
[2] Ciber Enfermedades Resp Ciberes, Barcelona, Spain
[3] Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Serv Cirurg Torac, Barcelona, Spain
关键词
BOS; bronchoalveolar lavage; chronic rejection; cytokines; RAS; BRONCHIOLITIS-OBLITERANS-SYNDROME; BRONCHOALVEOLAR LAVAGE; COMPUTED-TOMOGRAPHY; SYNDROME RAS; REJECTION; HEART; EXPRESSION; THERAPY; TH1; AZITHROMYCIN;
D O I
10.1111/ctr.12898
中图分类号
R61 [外科手术学];
学科分类号
摘要
The long-term success of lung transplantation (LT) is limited by chronic lung allograft dysfunction (CLAD). Different phenotypes of CLAD have been described, such as bronchiolitis obliterans syndrome (BOS) and restrictive allograft syndrome (RAS). The purpose of this study was to investigate the levels of cytokines and chemokines in bronchoalveolar lavage fluid (BALF) as markers of these CLAD phenotypes. BALF was collected from 51 recipients who underwent (bilateral and unilateral) LT. The study population was divided into three groups: stable (ST), BOS, and RAS. Levels of interleukin (IL)-4, IL-5, IL-6, IL-10, IL-13, tumor necrosis factor alpha (TNF-), interferon-gamma (IFN-), and granulocyte-macrophage colony-stimulating factor (GM-CSF) were measured using the multiplex technology. BALF neutrophilia medians were higher in BOS (38%) and RAS (30%) than in ST (8%) (P=.008; P=.012). Regarding BALF cytokines, BOS and RAS patients showed higher levels of INF- than ST (P=.02; P=.008). Only IL-5 presented significant differences between BOS and RAS (P=.001). BALF neutrophilia is as a marker for both CLAD phenotypes, BOS and RAS, and IL-5 seems to be a potential biomarker for the RAS phenotype.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] PHENOTYPES IN CHRONIC LUNG ALLOGRAFT DYSFUNCTION
    Auner, Sophia
    Berezhinskiy, Hatice Oya
    Boehm, Panja M.
    Morscher, Annika
    Schwarz, Stefan
    Frick, Anna E.
    Schweiger, Thomas
    Hoda, Alireza Mir
    Moser, Bernhard
    Matilla, Jose Ramon
    Murakozy, Gabriela
    Lang, Gyoergy
    Taghavi, Shahrokh
    Klepetko, Walter
    Hoetzenecker, Konrad
    Jaksch, Peter
    Benazzo, Alberto
    TRANSPLANT INTERNATIONAL, 2021, 34 : 17 - 17
  • [2] Chronic lung allograft dysfunction phenotypes and treatment
    Verleden, Stijn E.
    Vos, Robin
    Vanaudenaerde, Bart M.
    Verleden, Geert M.
    JOURNAL OF THORACIC DISEASE, 2017, 9 (08) : 2650 - 2659
  • [3] Survival Determinants in Lung Transplant Patients With Chronic Allograft Dysfunction
    Verleden, Geert M.
    Vos, Robin
    Verleden, Stijn E.
    De Wever, Walter
    De Vleeschauwer, Stephanie I.
    Willems-Widyastuti, Anna
    Scheers, Hans
    Dupont, Lieven J.
    Van Raemdonck, Dirk E.
    Vanaudenaerde, Bart M.
    TRANSPLANTATION, 2011, 92 (06) : 703 - 708
  • [4] Mechanistical differences of chronic lung allograft dysfunction phenotypes in lung transplantation
    Suwara, Monika I.
    Vanaudenaerde, Bart M.
    Verleden, Stijn E.
    Borthwick, Lee A.
    Vos, Robin
    Green, Nicola J.
    Ward, Chris
    Van Raemdonck, Dirk E.
    Corris, Paul A.
    Mann, Derek A.
    Verleden, Geert M.
    Fisher, Andrew J.
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [5] Changing the curve in chronic lung allograft dysfunction: Implications of chronic lung allograft dysfunction phenotypes in assessing treatment interventions
    Mooney, Joshua J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2018, 37 (03): : 319 - 320
  • [6] Outcome of Lung Re-Transplant in Chronic Lung Allograft Dysfunction
    Charoenpong, P.
    Song, D.
    Ford, D.
    Daoud, N.
    Adedeji, A.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2021, 40 (04): : S303 - S304
  • [7] Simkania negevensis and Chronic Lung Allograft Dysfunction in Lung Transplant Recipients
    Aguilar, C.
    Li, Y.
    Martinu, T.
    Tikkanen, J.
    Kent, W.
    Juvet, S.
    Humar, A.
    Kumar, D.
    Kolls, J. K.
    Keshavjee, S.
    Singer, L. G.
    Husain, S.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2018, 37 (04): : S176 - S176
  • [8] Linking clinical phenotypes of chronic Lung allograft dysfunction to changes in lung structure
    Verleden, Stijn E.
    Vasilescu, Dragos M.
    McDonough, John E.
    Ruttens, David
    Vos, Robin
    Vandermeulen, Elly
    Bellon, Hannelore
    Geenens, Rachel
    Verbeken, Erik K.
    Verschakelen, Johny
    Van Raemdonck, Dirk E.
    Wuyts, Wim A.
    Sokolow, Youri
    Knoop, Christiane
    Cooper, Joel D.
    Hogg, James C.
    Verleden, Geert M.
    Vanaudenaerde, Bart M.
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46 (05) : 1430 - 1439
  • [9] Impact of Transplant Laterality on Chronic Lung Allograft Dysfunction
    Elshikh, A.
    Hill, M.
    Ali, A.
    Warrior, K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [10] Association of methacholine challenge test with diagnosis of chronic lung allograft dysfunction in lung transplant patients
    Siddiqui, Atif S.
    Kumar, Gagan
    Majumdar, Tilottama
    Graviss, Edward A.
    Nguyen, Duc T.
    Goodarzi, Ahmad
    Kaleekal, Thomas
    CLINICAL TRANSPLANTATION, 2018, 32 (10)